Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhen He

Showing results (991-1000 of 1,002) with videos related to

Pageof 101
Sort By:
Medical Image Analysis|August 9, 2025
OCELOT 2023: Cell detection from cell-tissue interaction challengeJaeWoong Shin, Jeongun Ryu, Aaron Valero Puche, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 26, 2022
Boosting the reaction kinetics in aprotic lithium-carbon dioxide batteries with unconventional phase metal nanomaterialsJingwen Zhou, Tianshuai Wang, Lin Chen, et al.
Science Immunology|December 19, 2025
CD27 agonism enhances long-lived CD4 T cell vaccine responses critical for antitumor immunityBin-Jin Hwang, Erika J Crosby, David T Severson, et al.
Experimental Biology and Medicine (Maywood, N.J.)|November 7, 2017
Changes in the metabolome and microRNA levels in biological fluids might represent biomarkers of neurotoxicity: A trimethyltin studySyed Z Imam, Zhen He, Elvis Cuevas, et al.
Advanced Materials (Deerfield Beach, Fla.)|March 11, 2022
Confined Growth of Silver-Copper Janus Nanostructures with {100} Facets for Highly Selective Tandem Electrocatalytic Carbon Dioxide ReductionYangbo Ma, Jinli Yu, Mingzi Sun, et al.
Nature Communications|January 3, 2025
Unconventional hexagonal open Prussian blue analog structuresJinwen Yin, Jing Wang, Mingzi Sun, et al.
Med (New York, N.Y.)|May 14, 2026
Neoadjuvant mFOLFOXIRI with or without cadonilimab versus mFOLFOX6 in locally advanced colorectal cancer: A randomized phase 2 trial (OPTICAL-2)Jianwei Zhang, Sifan Qi, Huabin Hu, et al.
Cancer Cell|December 5, 2017
Antibody Tumor Targeting Is Enhanced by CD27 Agonists through Myeloid RecruitmentAnna H Turaj, Khiyam Hussain, Kerry L Cox, et al.
Nature Communications|August 7, 2025
Galectin-3-integrin α5β1 phase separation disrupted by advanced glycation end-products impairs diabetic wound healing in rodentsZhongyu Zhang, Zhengde Zhao, Xiuyi Huang, et al.
The Lancet. Oncology|July 1, 2026
Neoadjuvant toripalimab plus celecoxib versus toripalimab monotherapy for mismatch repair-deficient or microsatellite instability-high, locally advanced colorectal cancer (PICC-2): an open-label, multicentre, randomised, phase 2 trialHuabin Hu, Xutao Shen, Yunfeng Li, et al.
Pageof 101

Showing results (991-1000 of 1,002) with videos related to

Sort By:
Pageof 101
Medical Image Analysis|August 9, 2025
OCELOT 2023: Cell detection from cell-tissue interaction challengeJaeWoong Shin, Jeongun Ryu, Aaron Valero Puche, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 26, 2022
Boosting the reaction kinetics in aprotic lithium-carbon dioxide batteries with unconventional phase metal nanomaterialsJingwen Zhou, Tianshuai Wang, Lin Chen, et al.
Science Immunology|December 19, 2025
CD27 agonism enhances long-lived CD4 T cell vaccine responses critical for antitumor immunityBin-Jin Hwang, Erika J Crosby, David T Severson, et al.
Experimental Biology and Medicine (Maywood, N.J.)|November 7, 2017
Changes in the metabolome and microRNA levels in biological fluids might represent biomarkers of neurotoxicity: A trimethyltin studySyed Z Imam, Zhen He, Elvis Cuevas, et al.
Advanced Materials (Deerfield Beach, Fla.)|March 11, 2022
Confined Growth of Silver-Copper Janus Nanostructures with {100} Facets for Highly Selective Tandem Electrocatalytic Carbon Dioxide ReductionYangbo Ma, Jinli Yu, Mingzi Sun, et al.
Nature Communications|January 3, 2025
Unconventional hexagonal open Prussian blue analog structuresJinwen Yin, Jing Wang, Mingzi Sun, et al.
Med (New York, N.Y.)|May 14, 2026
Neoadjuvant mFOLFOXIRI with or without cadonilimab versus mFOLFOX6 in locally advanced colorectal cancer: A randomized phase 2 trial (OPTICAL-2)Jianwei Zhang, Sifan Qi, Huabin Hu, et al.
Cancer Cell|December 5, 2017
Antibody Tumor Targeting Is Enhanced by CD27 Agonists through Myeloid RecruitmentAnna H Turaj, Khiyam Hussain, Kerry L Cox, et al.
Nature Communications|August 7, 2025
Galectin-3-integrin α5β1 phase separation disrupted by advanced glycation end-products impairs diabetic wound healing in rodentsZhongyu Zhang, Zhengde Zhao, Xiuyi Huang, et al.
The Lancet. Oncology|July 1, 2026
Neoadjuvant toripalimab plus celecoxib versus toripalimab monotherapy for mismatch repair-deficient or microsatellite instability-high, locally advanced colorectal cancer (PICC-2): an open-label, multicentre, randomised, phase 2 trialHuabin Hu, Xutao Shen, Yunfeng Li, et al.
Pageof 101